A pair of Nevada Democratic senators introduced a bill last week to allow research on psilocybin, or psychedelic mushrooms, as well as the drug MDMA, drawing inspiration from states like Oregon and Colorado where the substance has been legalized.
proposal or offer, According to the official legislative summary of the procedurewill establish “procedures for a research facility to obtain approval from the Department of Health and Human Services to conduct certain studies involving certain controlled substances; decriminalize certain conduct by persons 18 years of age or older that includes psilocybin and MDMA if it is conducted in connection with and within the scope of an approved study; Decriminalize certain conduct by persons 18 years of age or older that involves 4 ounces or less of psilocybin or psilocin-producing fungi; and properly present other related matters.”
In more simple English, for every Las Vegas Sunit would “decriminalize psychedelic mushrooms and MDMA for the purpose of studying their effects on a range of behavioral health disorders” and “allow the Nevada Department of Health and Human Services to begin accepting applications from research institutions to use the drugs to treat conditions such as post-traumatic stress disorder, depression, anxiety and addiction.” “.
The bill was introduced by Democratic state senators Rochelle Nguyen and Fabian Dunnett, who both represent Las Vegas.
The bill also has two co-sponsors in the state House of Representatives: Max Carter and Elaine Marzola, who are also both Democrats.
Las Vegas Weekly It reported last fall that Nguyen had “submitted a draft request to the 2023 legislative session for a bill” that would “review provisions governing controlled substances” and “deal with issues of decriminalization, regulation and research on narcotic drugs,” which she said at the time “could help exacerbate a health crisis.” mentality.”
Psychedelic drugs like mushrooms and MDMA have emerged as a new focal point for drug reform advocates, with scientists and medical professionals increasingly drawn to their potential therapeutic benefits.
Las Vegas Weekly I mentioned that Nguyen specifically highlighted the example of Oregon, which legalized psilocybin in 2020.
Late last year, the Oregon Health Authority finalized the rules of the new psilocybin law, with particular regard to accessibility, affordability, and public safety.
“The final rules on the duration of administration sessions were revised to create a new standard for subcognitive doses. These doses are defined as products containing less than 2.5 mg of a psilocybin protease. After the client’s initial session, the Oregon Health Authority said at the time. The minimum dose duration of 2.5 mg psilocybin analyzer or less is 30 minutes.
Last year, voters in Colorado approved a measure to legalize psilocybin.
Perhaps this triggered a trend in the western mountain region. In addition to last week’s proposal in Nevada, Activists in Utah have also ramped up Attempt to legalize psilocybin mushrooms for medicinal purposes.
Luz Escamilla, the Democratic leader in Utah’s Senate, introduced a bill last month that would allow individuals 21 and older with qualifying conditions such as depression or anxiety to access psilocybin-assisted treatment directly from a psilocybin treatment provider.
“Hemp has given us a really good opportunity to understand that we can use other natural things…to help us. Now, we have to be careful, and I think we have really good safeguards,” Escamilla said.
“This is not a free-for-all,” Escamilla added. “It’s not for everyone, but if it’s someone who’s desperate (for help) with their anxiety, depression, PTSD – it’s driving many, unfortunately, to suicide, I want them to have access in a way that’s safe, that they can organize.”